Who owns Brainstorm Cell Therapeutics?
- CUSIP Number: 10501e201
Tip: Access positions for across all investors
Analyze quarterly positions in Brainstorm Cell Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Brainstorm Cell Therapeutics stock
Who bought or sold Brainstorm Cell Therapeutics this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Geode Capital Management | 683k | $152k | 41% | Sep 2024 |
|
| BlackRock | 378k | $87k | 100% | Sep 2024 |
|
| Liberty Wealth Management | 340k | $78k | 0% | Sep 2024 |
|
| Weaver Consulting Group | 234k | $54k | 0% | Sep 2024 |
|
| Susquehanna International | 150k | $35k | -1% | Sep 2024 |
|
| Northern Trust | 112k | $26k | 100% | Sep 2024 |
|
| Raymond James & Associates | 95k | $22k | -14% | Sep 2024 |
|
| Jmac Enterprises | 65k | $15k | 0% | Sep 2024 |
|
| Wells Fargo & Company | 53k | $12k | 83% | Sep 2024 |
|
| Group One Trading | 47k | $11k | 0% | Sep 2024 |
|
| Tru Independence Asset Management 2 | 44k | $10k | 100% | Sep 2024 |
|
| Citadel Advisors | 40k | $9.3k | -14% | Sep 2024 |
|
| Janney Montgomery Scott | 21k | $5.0k | 0% | Sep 2024 |
|
| Creative Planning | 14k | $3.2k | -34% | Sep 2024 |
|
| Saxony Capital Management | 13k | $3.0k | 0% | Sep 2024 |
|
| Bank of New York Mellon | 12k | $2.8k | 0% | Sep 2024 |
|
| Jump Financial | 11k | $2.5k | 100% | Sep 2024 |
|
| Advisor Group Holdings | 11k | $2.4k | 100% | Sep 2024 |
|
| Activest Wealth Management | 5.0k | $1.2k | -29% | Sep 2024 |
|
| Bank of America Corporation | 1.6k | $370.574200 | 8% | Sep 2024 |
|
| Hartland & Co | 1.5k | $346.050000 | 0% | Sep 2024 |
|
| Simplex Trading | 1.2k | $0 | -79% | Sep 2024 |
|
| Reuter James Wealth Management | 1.0k | $238.026800 | 100% | Sep 2024 |
|
| Westside Investment Management | 200.00 | $46.000000 | 0% | Sep 2024 |
|
| Jpmorgan Chase & Co | 175.00 | $40.005000 | -31% | Sep 2024 |
|
| Northwestern Mutual Wealth Management Company | 161.00 | $36.997800 | 0% | Sep 2024 |
|
Who sold out of Brainstorm Cell Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Caldwell Sutter Capital | Jun 2024 | 157k | $0 |
| Abner, Herrman & BrocK | Jun 2024 | 146k | $49k |
| Ikarian Capital | Jun 2024 | 90k | $31k |
| Virtu Financial | Jun 2024 | 50k | $17k |
| Jane Street | Jun 2024 | 20k | $6.7k |
| Professional Financial Advisors | Jun 2024 | 17k | $5.8k |
| Sanctuary Advisors | Jun 2024 | 17k | $9.2k |
| First Affirmative Financial Network | Jun 2024 | 14k | $4.8k |
| Nelson, Van Denburg & Campbell Wealth Management | Jun 2024 | 11k | $3.8k |
| LPL Financial | Jun 2024 | 10k | $3.4k |
| Bangor Savings Bank | Sep 2024 | 4.0k | $920.800000 |
| EverSource Wealth Advisors | Jun 2024 | 2.1k | $727.988800 |
| VisionPoint Advisory Group | Jun 2024 | 1.9k | $658.044000 |
| Cranbrook Wealth Management | Jun 2024 | 1.0k | $339.000000 |
| Royal Bank of Canada | Jun 2024 | 529.00 | $0 |
| D. J. St. Germain | Jun 2024 | 500.00 | $169.000000 |
| Bnp Paribas Arbitrage, Snc | Jun 2024 | 364.00 | $122.995600 |